Current Issue

Original Research Article Open Access

Microalbuminuria among Newly Diagnosed Diabetic Patients at Mulago National Referral Hospital in Uganda: A Cross Sectional Study

Muddu Martin, Mutebi Edrisa, Isaac SSinabulya, Kizito Samuel, Mulindwa Frank and Mondo Charles Kiiza
J Obes Weight-Loss Medic Volume 4, Issue 1

Abstract: Microalbuminuria is an early marker of nephropathy, cardiovascular diseases and severe ocular morbidity in adults with diabetes mellitus. This subclinical condition is associated with high morbidity and mortality. Microalbuminuria precedes the development of overt diabetic nephropathy by 10-14 years. At this stage, one can reverse diabetic nephropathy or prevent its progression. Unfortunately, tests to detect microalbuminuria in diabetics are not routinely done in Uganda. This study sought to determine the prevalence and factors associated with microalbuminuria among newly diagnosed diabetic patients in the National Referral Hospital in Uganda.

PDF   Full Text   DOI: 10.23937/2572-4010.1510021

Original Article Open Access

Gene Polymorphism of Adiponectin SNP + 45 with Reference to Thyroid Status - A Comparative Study among Non-Obese, Overweight and Obese Type 2 Diabetics

Rajendran Jayanthi, Abu Raghavan Srinivasan and Gopal Niranjan
J Obes Weight-Loss Medic Volume 4, Issue 1

Abstract: 150 Type 2 diabetics of both genders who had visited the tertiary health care clinics during the stipulated study period were included. Based on BMI (18.50 to 24.99, 25 to 29.99 and ≥ 30 respectively), they were segregated into non-obese, overweight and obese (n = 28, n = 76 and n = 46 respectively). The cardio-metabolic risk factors were assessed through parameters including anthropometric and routine biochemical measures, besides glycemic status and insulin resistance.

PDF   Full Text   DOI: 10.23937/2572-4010.1510020

Research Article Open Access

Effects of Supersession Prescription/Metformin Combination Therapy in Overweight and Obese Individuals with Type 2 Diabetes

Yiyuan Zheng, Dan Fang, Miao Wang, Xiaogang Ma, Meng Xu and Songhua He
J Obes Weight-Loss Medic Volume 3, Issue 2

Abstract: This study was a 13-week, open-labeled, randomized parallel controlled study. Patients were randomly assigned to the treated and control groups in a 1:1 ratio. Both groups were provided metformin at the dosage of 750 mg twice daily as the primary treatment and the Supersession Prescription was given to the treated group as a supplementary treatment.

PDF   Full Text   DOI: 10.23937/2572-4010.1510019

Volume 3
Issue 2